Ravaggi A, Zonaro A, Mazza C, Albertini A, Cariani E
Institute of Chemistry, School of Medicine, University of Brescia, Italy.
J Clin Microbiol. 1995 Feb;33(2):265-9. doi: 10.1128/jcm.33.2.265-269.1995.
The direct detection of hepatitis C virus (HCV) RNA by PCR is widely used to determine the presence of circulating virions. The most relevant limit of this approach is the lack of quantitative information about the viral titer. We report a technique of competitive amplification allowing the estimation of HCV RNA copy number in biological samples. We constructed a standard competitive RNA template containing only two point mutations compared with its wild-type counterpart. The competitor was added in titrated amounts to the target RNA, and the mixture was then reverse transcribed and amplified in the same reaction tube. The relative amounts of target and competitor were determined by differential hybridization on microtiter plates with nonradioactive probes. The evaluation of HCV RNA titer required a single coamplification with the competitor and could be read from a standard curve. Furthermore, this method proved suitable for amplification of HCV RNA directly from serum, thus avoiding the intrinsic variability of the RNA extraction step.
通过聚合酶链反应(PCR)直接检测丙型肝炎病毒(HCV)RNA被广泛用于确定循环病毒粒子的存在。这种方法最相关的局限性在于缺乏关于病毒滴度的定量信息。我们报告了一种竞争性扩增技术,可用于估计生物样品中HCV RNA的拷贝数。我们构建了一个标准竞争性RNA模板,与野生型对应物相比仅含有两个点突变。将竞争者以滴定的量加入到靶RNA中,然后将混合物在同一反应管中进行逆转录和扩增。通过使用非放射性探针在微量滴定板上进行差异杂交来确定靶标和竞争者的相对量。评估HCV RNA滴度只需与竞争者进行一次共扩增,并且可以从标准曲线读取结果。此外,该方法被证明适用于直接从血清中扩增HCV RNA,从而避免了RNA提取步骤固有的变异性。